On behalf of the CGA-IGC Executive Council, I would like to express my humblest gratitude to our patient advocacy and non-profit partners. These organizations inspire CGA-IGC to always center the voice of patients—they remind us of why we do what we do. As we head into the excitement of the annual meeting, I extend my heartfelt thank you to our partners for their support of CGA-IGC. We look forward to many years of continued partnership and collaboration to advance the care

If you missed the live webinar, you can now watch the recording of this engaging webinar. The GCA-IGC Research Committee are the organizers of the "Tips and Tricks for development of a clinical registry” webinar, which explores the development and sustainability of a Hereditary Gastrointestinal Cancer Registry. Our three speakers, both US-based and international, cover topics including identification of patients who meet inclusion criteria for registry enrollment, essential

Episode 7 is now out! "We showed that we can detect UGI cancer at an early stage, but the standard should be to prevent cancer". This episode is hosted by Pooja Dharwadkar, M.D, assistant professor at the University of California San Francisco, and features a discussion between Carol Burke, M.D, codirector of the Hereditary Cancer Clinic at the Cleveland Clinic; Robert Hüneburg, M.D, gastroenterologist at the National Center for Hereditary Tumor Syndromes at University Hospit

The GCA-IGC Research Committee invites you to attend “Tips and Tricks for development of a clinical registry”, a webinar exploring the development and sustainability of a Hereditary Gastrointestinal Cancer Registry. Our three speakers, both US-based and international, will cover topics including identification of patients who meet inclusion criteria for registry enrollment, essential data points to collect for each patient, how to interact with the existing EMR and overall ch

Join us on October 18th at 1pm ET / 10am PT for the last webinar of the 2022 CGA-IGC Webinar Series! Focusing on the When labs don't agree: discordant variant classifications, confusing laboratory updates, and challenges in clinical management - following the Challenging Cases webinar you will be able to: illustrate three different scenarios related to differences in variant classification through cancer genetic counseling cases; compare the information provided by different

Courtesy of ICARE Polymerase proof-reading associated polyposis (PPAP) is a rare hereditary polyposis condition. It is caused by mutations in an important region of the POLE and POLD1 genes called the exonuclease domain. Individuals often develop at least a dozen polyps, but this number can vary, ranging from zero or one to 100 polyps. Adenomas are the predominant polyp type seen with PPAP, and the lifetime risk for colon cancer is estimated to be at least 50%. The mutatio